Skip to main content
Cold Spring Harbor Perspectives in Biology logoLink to Cold Spring Harbor Perspectives in Biology
. 2022 Aug;14(8):a041235. doi: 10.1101/cshperspect.a041235

Wound Healing from an Actin Cytoskeletal Perspective

Parinaz Ahangar 1, Xanthe L Strudwick 1, Allison J Cowin 1
PMCID: PMC9341468  PMID: 35074864

Abstract

Wound healing requires a complex cascade of highly controlled and conserved cellular and molecular processes. These involve numerous cell types and extracellular matrix molecules regulated by the actin cytoskeleton. This microscopic network of filaments is present within the cytoplasm of all cells and provides the shape and mechanical support required for cell movement and proliferation. Here, an overview of the processes of wound healing are described from the perspective of the cell in relation to the actin cytoskeleton. Key points of discussion include the role of actin, its binding proteins, signaling pathways, and events that play significant roles in the phases of wound healing. The identification of cytoskeletal targets that can be used to manipulate and improve wound healing is included as an emerging area of focus that may inform future therapeutic approaches to improve healing of complex wounds.


Wound healing is an essential process that ensures body fluid preservation, hemostasis, thermoregulation, and protection against physical injuries and environmental insults (Adzick 1992). It is a highly orchestrated process consisting of four overlapping phases: hemostasis, inflammation, proliferation, and remodeling (Shaw and Martin 2009), which, in healthy individuals, leads to the restoration of tissue function. While the gross physiological end point is a healed piece of skin, this is the culmination of a complex cascade of highly controlled and conserved cellular and molecular processes involving numerous cell types, proteins, extracellular matrix (ECM) molecules, and sensing of environmental cues, all of which involve or are regulated by the cytoskeleton (Abreu-Blanco et al. 2012).

The actin cytoskeleton is a microscopic network of filaments present within the cytoplasm of cells, which gives them shape and provides mechanical support required for cell movement and proliferation. In eukaryotic cells, the cytoskeleton consists of three types of filaments that have different size, dynamics, and protein content: microfilaments, intermediate filaments, and microtubules all of which are regulated by a number of cytoskeletal remodeling proteins (Fletcher and Mullins 2010). This review will overview the processes of wound healing from the cellular perspective particularly in relation to the role of the actin cytoskeleton. The focus will primarily be related to actin and its binding proteins, which are known to play significant roles in the wound repair process.

CYTOSKELETAL BASICS

Cytoskeletal Filaments

The cytoskeleton is composed of three major types of filaments that are involved in cell division, cell motility, and cytoplasmic streaming. Actin filaments are composed of globular actin (G-actin) monomers, which interact with other G-actins to polymerize and create double-strand helix actin filaments (F-actin) (Hohmann and Dehghani 2019). Differences in the rate of actin polymerization (elongation) between the two ends of actin filaments create polarity, and the end with the highest rate of actin polymerization is called the plus or barbed end, whereas the end with slower polymerization rates is called the pointed or minus end (Fig. 1A; Pollard 2016). Intermediate filaments include keratins and vimentin and can be found in homopolymers and heteropolymers with each other (Fig. 1B). Emerging evidence demonstrates a vital role of these filaments in mechanically introduced signal transduction, cell proliferation, and migration (Sanghvi-Shah and Weber 2017). Microtubules are large polar and dynamic cytoskeletal structures consisting of α- and β-tubulin heterodimers (Goodson and Jonasson 2018). Similar to microfilaments, microtubules also have polymerization and shrinkage states in their ends; however, through a process called dynamic instability, these ends can switch from a polymerizing, extension end to a depolymerizing, shrinkage end, and vice versa (Fig. 1C). Microtubules are involved in cell motility, intracellular transport, mitosis, and maintenance of cell shape (Horio and Murata 2014).

Figure 1.

Figure 1.

Sketch of the three main components of the actin cytoskeleton. (A) Microfilaments: F-actin filaments consisting of G-actin monomers. Actin bundles are created from F-actin filaments cross-linked by fimbrin or α-actinin. Actin networks are composed of F-actin filaments cross-linked by filamin or Arp2/3. (B) Intermediate filaments (IFs): IFs are built from IF monomers that bind together to form dimers, tetramers, octamers, and long IFs. (C) Microtubules: Microtubules are built from α- and β-tubulin dimers. Microtubules are dynamic structures that have polymerization and shrinkage states at their ends.

Actin-Binding Proteins

The assembly and disassembly of actin filaments is regulated by different groups of proteins termed actin-binding proteins (ABPs) (Pollard 2016). Actin nucleation/elongation factors such as formins, Arp2/3, and profilins promote the nucleation of actin monomers and the elongation of actin filaments by facilitating the addition of G-actins to the plus ends of the filaments. They also act as nucleotide-exchange factors and are involved in the removal of capping proteins (Chesarone and Goode 2009). These proteins assist lamellipodia and filopodia formation to facilitate cell migration. Actin nucleation is promoted by several nucleation-promoting factors such as the Wiskott–Aldrich syndrome protein (WASP) and WASP-family verprolin-homologous (WAVE) family protein, which interact with actin nucleation factors and regulate their function (Stradal et al. 2004). Conversely, cytosolic protein thymosin β4 inhibits actin filament assembly (Goldschmidt-Clermont et al. 1992).

The actin-depolymerization factor (ADF)/cofilin family of ABPs regulate actin filaments by severing and breaking them into shorter filaments. These severing proteins are responsible for actin turnover and are able to create new plus ends for actin polymerization (Pavlov et al. 2007). Severing proteins may stay physically located at the plus end of actin filaments forming a cap that restricts further elongation and promoting branched filament networks (Edwards et al. 2014). Actin filaments can also be capped by other proteins such as CapZ protein and tropomodulin. These do not sever the filaments but only cap the plus and minus end, respectively, and stabilize the actin filaments (Bao et al. 2012). When actin filaments are created, they mainly assemble into either packed actin bundles or semisolid gel-like actin networks. In bundles, the actin filaments are cross-linked by small cross-linking proteins such as α-actinin and fimbrin (Klein et al. 2004). In networks, the actin filaments are loosely cross-linked by large protein families such as filamin (Stossel et al. 2001).

Gelsolin is known as the most abundant and important ABP and heads the superfamily to which it lends its name, which consists of seven other proteins: Flightless I, supervillin, villin, advillin, CapG, adseverin, and adseverin D5 (Fig. 2; Silacci et al. 2004). Gelsolin is a Ca2+-dependent, actin-nucleating, capping, severing, and monomer-sequestering protein that regulates actin cytoskeleton formation and reorganization (Gremm and Wegner 2000). Its function is regulated by PIP2 levels, temperature, and pH (Badmalia et al. 2017). Gelsolin has three isoforms that arise by alternative splicing from the same gene: intracellular or cytoplasmic gelsolin (cGSN), extracellular or plasma gelsolin (pGSN), and gelsolin 3 (Vouyiouklis and Brophy 1997). They all have multiple intra- and extracellular functions and are involved in cellular interactions (Li et al. 2012). pGSN has an extension of 23 amino acids from its amino terminal, which leads to a slightly higher molecular weight (about 83 kD) than cGSN (80 kD) (Li et al. 2012). All gelsolin isoforms consist of six repeats of gelsolin domains (G1–6) sequencing from the amino terminus, and each contains a Ca2+-binding site (Burtnick et al. 1997). However, just three of these domains, G1–3, are Ca2+-dependent, whereas the function of the G4–G6 domains does not require Ca2+. Other members of the gelsolin superfamily also contain a variety of copies of gelsolin domains. CapG has three gelsolin-type domains, supervillin has five, and each of the others have six repeats (Fig. 2; Nag et al. 2013).

Figure 2.

Figure 2.

Structure and function of the gelsolin family. Schema showing gelsolin family of actin-binding proteins with conserved gelsolin domains (G1–6) and additions including a leucine-rich repeat (LRR), nuclear localization signal (NLS), or a carboxy-terminal head piece domain (H).

Flightless I (Flii) is a unique member of the family with multifunctional roles in wound healing (Cowin et al. 2007; Kopecki and Cowin 2008; Strudwick and Cowin 2020). It has all six of the gelsolin-type domains, but only two Ca2+-binding sites (Nag et al. 2013) and has an additional amino-terminal leucine-rich repeat (LRR) domain enabling interactions with other proteins and lipids (Fig. 2; Liu and Yin 1998). Whereas Flii binds both globular (G)- and filamentous (F)-actin through the gelsolin domain (Liu and Yin 1998) inhibiting polymerization and capping the barbed end of F-actin, it does not possess actin-severing ability (Mohammad et al. 2012). Flii localizes with actin- and β-tubulin-based structures at the cell periphery (Davy et al. 2001), acting as a regulator of migration in multiple cell types (Strudwick and Cowin 2020). Similar to gelsolin, Flii is also found in both intracellular and extracellular compartments and plasma Flii (pFlii) is found in plasma and wound fluid of human patients (Ruzehaji et al. 2014). Flii further influences cytoskeletal dynamics, enhancing the formation of actin into filaments by Rho-induced formins, activating them by preventing their autoinhibition and recruiting G-actin and preformed F-actin (Goshima et al. 1999; Higashi et al. 2010).

Rho GTPase Family

Acting upstream of the ABPs, Rho GTPases (Rho, Rac, and Cdc42) act as key regulators of the actin cytoskeleton, controlling signal transduction pathways by linking cell surface receptors to intracellular responses (Raftopoulou and Hall 2004). Rho GTPases broadly influence many aspects of cell behavior including microtubule dynamics, vesicular trafficking, and gene expression (Raftopoulou and Hall 2004). Stress fiber formation and cell contraction is more specifically controlled by Rho, the formation of lamellipodial protrusions and membrane ruffles by Rac and filopodial extensions to control cell polarity by Cdc42 (Hall 2005). Cdc42 is also a regulator of filopodia formation, which mediates WASP and Arp2/3 factors and stimulates actin polymerization (Tomasevic et al. 2007).

Rho-associated protein kinase (ROCK) is the major effector protein of Rho, which phosphorylates several substrates on threonine and serine and regulates cell proliferation, migration, and adhesion (Amano et al. 2010). Active Rho also interacts with the mDia protein isoforms (mDia1-3), members of the formin family of actin-nucleating factors, which together with ROCK mediate Rho-induced actin reorganization (Lammers et al. 2008; Kühn and Geyer 2014). The Rho GTPases affects several additional signal transduction pathways, including those mediated by the transcription factor NF-κB in turn, contributing to microtubule dynamics, gene transcription, cell–cell adhesion, cell-cycle progression, and enzyme transport, among other intracellular mechanisms (Van Aelst and D'Souza-Schorey 1997; Tong and Tergaonkar 2014).

Caveolin1 appears to play a critical role linking Rho GTPases and signaling molecules localized together at the lipid-rich microdomains at the plasma membrane known as caveolae, with changes in its expression being linked with impaired healing (Jozic et al. 2021). Thus, the dynamic control of the cytoskeleton is critically involved in the regulation of cell shape, migration, and proliferation, processes that are fundamental to all phases of wound healing.

CYTOSKELETAL INVOLVEMENT DURING HEMOSTASIS AND INFLAMMATION

In response to injury, disruption of blood vessels leads to leukocytes being released into the wound site and activation of a chain of events, which result in coagulation, platelet aggregation, and fibrin clot formation (Laurens et al. 2006). Platelets undergo a shape reformation to enable adhesion, activation, and aggregation, a process that is facilitated by cytoskeletal reorganization (Shin et al. 2017). Upon wounding, the actin cytoskeleton in platelets communicates with the ECM through the dystrophin–glycoprotein complex (DGC) and regulates cell morphology depending on the environmental geometry (Cerecedo 2013). Platelets adopt a spherical shape after adhesion to the matrix through reorganization of the cytoskeleton to filopodia and lamellipodia structures (Escolar et al. 1986). These actin structures assist platelet attachment and activation, enabling them to spread and sense the environment. Finally, to perform clot contractions, actin filaments organize into higher-order structures including stress fibers and contractile rings, which are composed of bundles of actin filaments and myosin II, allowing nonmuscle cells to apply contractile forces (Bearer et al. 2002).

The recruitment, circulation, and trafficking of innate immune cells, such as neutrophils, monocytes, and adaptive immune cells, such as B and T cells, to the wound bed, are crucial for a rapid and appropriate response to potential invading pathogens (Gonzalez et al. 2016). Leukocyte extravasation involves sequential and discrete stages including capture, rolling, adhesion, crawling, transendothelial migration (TEM), and migration through ECM (Muller 2013). The binding of L-selectin on leukocytes with E- and P-selectin on activated endothelial cells (ECs) results in the process of “leukocyte capture,” which slows the movement of the cells within the blood vessels. Subsequent breakage of these selectin tethers at the front and rear of the cells enables them to roll along the disrupted blood vessel wall (Anderson et al. 2000). An intact actin cytoskeleton plays a vital role in persistent rolling (Anderson et al. 2000), likely because the L-selectins on leukocytes are supported through their interactions with α-actinin, whereas E-selectin on ECs interacts with a complex of ABPs, including cortactin, filamin, vinculin, α-actinin, paxillin, and focal adhesion kinase (Dwir et al. 2001).

Rolling provides further activation of leukocytes by chemokines and other proinflammatory agents leading to the expression of integrins on both leukocytes and ECs (Zarbock et al. 2012). Integrins are heterodimer receptors composed of α and β subunits, which, upon activation through ligand binding, interact with the actin cytoskeleton through the β subunit cytoplasmic domain (Delon and Brown 2007). Integrin-mediated adhesions activate several tyrosine kinases, including FAK and Src, which eventually leads to the activation of Rac and Cdc42 on opposing sides of the cell to promote actin polymerization and cell polarization (DeMali et al. 2003). The activation of small GTPase Rac proteins and Cdc42 at the front edge leads to the activation of WASP, which organizes actin polymerization via the Arp2/3 complex, resulting in the formation of lamellar F-actin filaments and pseudopods around the leading edge (Innocenti 2018). Furthermore, GTPase Rac and Cdc42 inactivate both myosin light chain (MLC) kinase (MLCK) and myosin heavy chain II, which reduces contraction in the leading edge leading to its extension in migrating cells (Infante and Ridley 2013). Simultaneously, GTPase Rho protein activation at the rear of the cell leads to the formation of the uropod, an area poor in F-actin and rich in MLC and adhesion molecules, that is required for retraction of the trailing edge (Worthylake et al. 2001). This polarization provides a pushing force for fast, amoeboid-like motility, allowing cells to crawl along the endothelium in search of a proper location to breach the endothelial layer (Fig. 3; Ren et al. 2019).

Figure 3.

Figure 3.

Overview of the multiple steps of leukocyte extravasation. (A) Hematoxylin and eosin-stained tissue showing leukocyte extravasation. Arrows show neutrophils that are transmigrating from a blood vessel to the extracellular matrix (ECM). (B) Schematic overview of the multiple steps of leukocyte extravasation. Capture and rolling of leukocytes along the endothelium are mediated through interactions between E-selectins on endothelial cells (ECs) and L-selectins on leukocytes. The expression of integrins on leukocytes and ECs establish the firm adhesion between these cells. Leukocyte transendothelial migration (TEM) is facilitated by the adhesion molecule, platelet/EC adhesion molecule 1 (PECAM-1), intercellular adhesion molecule 1 (ICAM-1), and vascular cell adhesion molecule 1 (VCAM-1). TEM occurs through EC–cell junctions that are predominantly composed of adhesion molecules including PECAM-1, the junctional adhesion molecules (JAMs), and vascular endothelial (VE)-cadherin.

Transmigration mainly occurs through EC–cell junctions, which are predominantly composed of adhesion molecules including the platelet/EC adhesion molecule 1 (PECAM-1), the junctional adhesion molecules (JAMs), and vascular endothelial (VE)-cadherin (Reglero-Real et al. 2016). Firm adhesion of leukocytes induces cytoskeletal remodeling in ECs, mainly via depolarization of actin cytoskeleton, and EC contraction to form a gap that acts as an open transmigratory pore (Cook-Mills et al. 2004). The firm adhesion of leukocytes to the endothelial layer is enabled by enrichment of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) on the uropod of leukocytes as they crawl. Both ICAM-1 and VCAM-1 are located over F-actin-rich vertical microvilli projections that form before TEM and called “transmigratory cups” (Carman and Springer 2004; Yang et al. 2006), but are also clustered in an endothelial actin-rich docking structure containing other cytoskeletal components such as α-actinin, vinculin, and vasodilator-stimulated phosphoprotein (VASP), which anchors the leukocyte during TEM (Barreiro et al. 2002; Carman and Springer 2004; Schnoor 2015).

Once within the wound site, inflammatory cells use phagocytosis, exocytosis, and NETosis to fight pathogens and clear cellular debris. Phagocytosis of invading pathogens or cellular debris requires a coordinated adhesion between target and phagocytic cells as well as a dramatic change in cell shape driven by actin remodeling, which may be dependent upon either immunoglobulin receptors (FcRs) or complement receptors (Vicente-Manzanares and Sánchez-Madrid 2004). Activation of FcRs on phagocytic cells initiates a signaling pathway that activates SRC family kinases (SFKs) and spleen tyrosine kinase (SYK) and stimulates Rac, which promotes actin polymerization by Arp2/3 complex and stimulates the assembly of actin-rich “phagocytic cup” to form pseudopods that engulf the target, closing around in a zipper-like mechanism (Crowley et al. 1997). Cdc42 is also recruited to the phagocytic cups, which activates WASP, promoting actin polymerization leading to membrane protrusion and particle engulfing (Dart et al. 2012). The severing of actin filaments plays a vital role in inducing actin polymerization due to the increase in the concentration of barbed filament ends. This is where the addition of actin monomers takes place, with cGSN the major actin-severing protein in phagocytes localizing in phagosomes (Serrander et al. 2000), and playing a key role in FcR and integrin-mediated phagocytosis (Li et al. 2012). Macrophages may use different modes of engulfment in response to spatial constraints, either lamellipodial phagocytosis facilitated by the formation of lamellipodia by Arp2/3, or filopodial phagocytosis that involves the extension of filopodia by Dia and/or Ena (Davidson and Wood 2020). Cytoskeletal reorganization is also a key process in the formation of pathogen-capturing neutrophil extracellular traps (NETs) released by neutrophils within the wound bed (Thiam et al. 2020b). NETosis, the formation of these web-like DNA structures of decondensed chromatin coated with histones and other proteins including cytoskeletal proteins (Vorobjeva and Pinegin 2014; Pires et al. 2016), is initiated with rapid actin depolymerization, followed closely by remodeling of microtubule and vimentin cytoskeletons to facilitate the expulsion of DNA, with NET release blocked by inhibition of actin disassembly (Thiam et al. 2020a). NETosis has been shown to impair wound healing and its inhibition results in healing improvement (Wong et al. 2015).

The release of actin from damaged cells is a common feature in all types of injury. The conditions of ionic strength and composition, temperature, as well as the pH in the extracellular environment (such as blood plasma) favors the polymerized form of actin (Li et al. 2012). The presence of F-actin, released from dying cells into the bloodstream, may be fatal as it can cause microthrombi in the vasculature of both the surrounding tissue, and pulmonary system (Haddad et al. 1990) as well as contributing to inflammation. To combat this, the extracellular actin scavenging system (EASS) comprising two key proteins, pGSN, together with vitamin D–binding protein (DBP), has evolved to rapidly clear actin from the circulation (Li et al. 2012). Working together, pGSN scavenges and severs actin filaments released in the extracellular space following injury into G-actin (Lind et al. 1986), which allows DBP to rapidly form DBP–actin complexes and clear extracellular actin via the liver (Dahl et al. 2003; Delanghe et al. 2015; Kew 2019). Serious injuries such as burns and traumatic injuries results in large amounts of extracellular actin that consumes both DBP and pGSN, reducing their concentration in plasma (Grinnell et al. 1993; Dahl et al. 2003). Reduced pGSN levels in patient blood has also been used to predict high-risk morbidities including sepsis following burn injury (Mounzer et al. 1999). Thus, both within the cell, and in the surrounding extracellular space, actin and its associated binding proteins are critical to the early stages of wound repair.

CYTOSKELETAL REMODELING DURING THE PROLIFERATIVE PHASE

The generation of new tissue occurs during the proliferative phase of healing and includes reepithelialization of the wound and formation of new granulation tissue formation, which includes ECM deposition and angiogenesis, but also fibroblast proliferation/migration, lymphangiogenesis, nerve sprouting, etc.

Formation of Granulation Tissue and Reepithelialization

In response to growth factors released by residential fibroblasts, platelets, monocytes, and keratinocytes, fibroblasts from surrounding tissues proliferate and migrate into the wound bed where they produce and deposit new ECM (Bainbridge 2013; Gonzalez et al. 2016; desJardins-Park et al. 2018). Reepithelialization usually starts even before the migration of fibroblasts and occurs through keratinocytes proliferating and migrating from around the wound edges along the injured dermis and across the newly formed granulation tissue until they meet and fuse (Jacinto et al. 2001; Abreu-Blanco et al. 2012). The actin cytoskeleton plays an integral role in this part of the proliferative phase, which involves multicellular adhesion, migration, and proliferation.

Cell Adhesion and Spreading

Cell adhesion and spreading requires the formation of Rho-dependent stress fibers and focal adhesions that instigate sustained extracellular signal‐regulated kinase (ERK) signaling to induce cyclin D1 production (Welsh et al. 2001). Proteins that link cells to the ECM, or neighboring cells, such as integrins and cadherins, are subject to and act in response to forces found in 3D matrices. These scaffolds hold cells in space and use mechanical sensing through focal adhesions to regulate proliferation (Pruitt and Der 2001; Provenzano and Keely 2011), and it is now clear that integrins are both regulated by and control the activation of GTPases including Rho, Rac, and cdc42 to affect not only adhesion and migration but also proliferation (Schwartz and Shattil 2000; Schwartz and Assoian 2001; Hou et al. 2016).

Proliferation

Once proliferation is activated, cytoskeletal remodeling plays a key role in the generation of the two daughter cells and is reliant upon the coordinated assembly and action of the actomyosin contractile ring (Cheffings et al. 2016). The activation of Rho in turn activates nucleation of F-actin by formin resulting in the formation of long, unbranched actin filaments and ROCK promotes myosin II activation to stimulate ring formation (Matsumura 2005; Goode and Eck 2007). The contractile stress required for cleavage is driven by myosin motors sliding actin filaments to constrict the ring and form a membrane furrow (Glotzer 2009). Cortical actin flow may also contribute to contractile-ring assembly and the stabilization of the actin network through cross-linking; however, this process must remain reversible and dynamic to facilitate not only the generation and positioning of the contractile ring, but also its rapid disassembly during constriction to allow separation of the daughter cells (Salbreux et al. 2009; Gerien and Wu 2018). The partition required to divide the two new daughter cells relies on the formation of a new membrane, with exocytosis relying upon vesicle transport to the membrane surface predominantly along the microtubule and actin (Noordstra and Akhmanova 2017; Papadopulos 2017). Shorter, branched F-actin accumulates at the poles of the cells with bundles of microtubules forming the central spindle that regulates the formation of the cleavage furrow to complete cytokinesis (Glotzer 2009). Distinct molecular signatures differentiate epidermal stem cells that provide the proliferative pool of newly formed cells further back from the wound edge, while those at the leading edge are altered to assume a nonproliferative, migratory phenotype (Aragona et al. 2017).

Migration

The migration of fibroblasts and keratinocytes involve the formation of lamellipodia and filopodia at the leading edge of the cells (Fig. 4). Lamellipodia are broad, sheet-like projections and are essential for cellular migration (Millard and Martin 2008). Filopodia are highly dynamic thin structures, rich in long parallel actin and able to sense the substratum ahead of the leading edge. Intensive actin reorganization is required to create these leading-edge protrusions, which are regulated by a range of ABPs and the Rho GTPase family. Rac and Cdc42 are abundant at the leading edge, facilitating actin cycling, filopodia, and lamellipodia formation (Ridley 2015). Arp2/3/WASP complex supports the nucleation of new filaments extended from preexisting filaments and the creation of branched filament network (Egile et al. 2005; Rodnick-Smith et al. 2016). Actin filament elongation is modulated by actin depolymerization through capping and severing proteins, mainly, ADF/cofilin and gelsolin family members (Mazur et al. 2010; Gross 2013). Tropomyosins are actin-associating proteins that stabilize actin filaments and have an important role in temporal regulation of cell migration during wound healing (Phillips et al. 1979; Lees et al. 2013). Cross-linking proteins like actinins have been found in the lamellipodia region, increasing the stability of actin filaments (Hamill et al. 2013). On the other pole, Rho at the trailing edge regulates ROCK, which in turn promotes stress fiber formation by inhibiting actin filament depolymerization and phosphorylating the MLC leading to actin contraction and rear retraction (Huveneers and Danen 2009).

Figure 4.

Figure 4.

Schematic overview of cytoskeleton involvement in cell migration. Cells acquire morphological polarity due to external signals. At the leading edge, actin assembly leads to the creation of membrane protrusions including lamellipodia (mainly actin networks) and filopodia (mainly actin bundles). Cdc42 is the main GTPase contributing to filopodium extension, while Rac induces lamellipodium extension. Actomyosin contraction at the trailing edge mediates cell detachment at the rear of the cell and drives the cell forward. These contractions at the trailing edge are mediated by Rho. (ECM) Extracellular matrix.

When Rac1 is activated by the guanine nucleotide exchange factor (GEF) P-Rex-1 at the leading edge, thin membrane protrusions rich in polymerized actin form and cells assume an elongated migratory phenotype. In contrast, Tiam1 activation of Rac1 inhibits migration with increased membrane ruffling and localization of actin at cell–cell contacts (Marei et al. 2016). The ABP Flii preferentially binds active Rac1 and its activator P-Rex1, mediating cell contraction and migration through the phosphorylation of MLC and activation of myosin II (Marei et al. 2016). Flii negatively regulates migration through the promotion of stress fiber formation and impaired focal adhesion turnover (Kopecki et al. 2011; Strudwick and Cowin 2020). It increases the number and size of focal adhesions forming around the periphery of the cells and increases total F-actin levels (Kopecki et al. 2011). When Flii levels are high, impaired spreading and a reduction of filopodial processes is observed (Kopecki et al. 2009; Arora et al. 2015), with increased stable focal complexes and impaired turnover due to inhibition of paxillin phosphorylation, increased α-actinin expression, and suppression of the Src and p130Cas signaling pathways (Kopecki et al. 2009, 2011). Conversely, low levels of Flii reduce formation of focal adhesions containing vinculin and activated β1 integrins are reduced, with greater incorporation of G-actin into nascent filaments at focal adhesions (Mohammad et al. 2012). As wound healing progresses and wound size is reduced, the frequency with which contralateral protrusions make contact with each other increase, and filopodia tether together in neighboring cells to mechanically close the wound in a zipper-like manner at the leading edge, without the use of an actin cable (Wood et al. 2002; Abreu-Blanco et al. 2012). Unlike adult wounds in which keratinocytes migrate over the granulation tissue using lamellipodia to close the gap, embryonic wounds are closed by actin contraction in a contractile purse string (Martin and Lewis 1992; Cowin et al. 2003).

Angiogenesis

Concurrent with keratinocyte and fibroblast migration into the wound bed, ECs activated by hypoxia and proangiogenic factors invade into the newly deposited ECM and form tube-like structures that mature to create blood vessels (Pugh and Ratcliffe 2003). Angiogenesis relies on EC migration and proliferation. Upon wounding, ECs embrace two distinct phenotypes classified as stalk and tip cells (Potente et al. 2011). Tip cells migrate into the wound bed and extend sprouts toward chemoattractants (mainly VEGF and FGF-2), which extend outward as gradients from existing vessels (Norton and Popel 2016). The filopodia of these tip cells sense the chemoattractants and cellular extension occurs by the formation of lamellipodia at the leading edge. These protrusions attach to the ECM through focal adhesions and stress fiber–mediated contraction, allowing forward movement while MLC phosphorylation at the rear and stress fiber–mediated traction forces allow rear retraction (Lamalice et al. 2007; Chen et al. 2019). Following tip cell migration, stalk cells, with fewer protrusions, proliferate and elongate to form a vascular lumen and support the elongation of new sprouts (Sauteur et al. 2014). ECs establish cell–cell junctions (mainly VE-cadherin) with their neighboring cells to guide and extend the sprout (Szymborska and Gerhardt 2018). These cells attach to the ECM with focal adhesion. Adhesive complexes of ECs including adherens and focal adhesions interact with the intracellular F-actin network. Proteins in actin-tethered junctional complexes regulate the actin cytoskeleton remodeling required for the migration, proliferation, and elongation of ECs (Zankov and Ogita 2015). VE-cadherin's indirect association with the intracellular F-actin network has been shown to promote F-actin polymerization and ECs elongation. (Sauteur et al. 2014). When filopodia of tip cells contact each other sprouts fuse by anastomosis to form new vascular loops. Once the contact is established, VE-cadherin-containing junctions consolidate the connection. Cell–cell adhesion suppresses migration and sprouting by increasing actomyosin contractility at cell junctions (Abraham et al. 2009). Eventually, the new vessel is stabilized by recruitment of pericytes and deposition of ECM that continues into the remodeling phase of wound healing (Szymborska and Gerhardt 2018).

CYTOSKELETAL CONTROL OF TISSUE REMODELING

Toward the end of the proliferative phase of wound repair, fibroblasts that have migrated into the provisional matrix generate traction forces that facilitate collagen reorganization (Harris et al. 1981; Gov 2009). This force is generated by myosin II heavy chain activity and is regulated by MLCK and ROCK (Tomasek et al. 2002; Beningo et al. 2006). The fibroblasts develop contractile microfilament bundles (stress fibers) under mechanical stress, and become proto-myofibroblasts (Tomasek et al. 2002). The increase in the mechanical tension of ECM and the presence of TGF-β lead to the creation of differentiated myofibroblasts characterized by the expression of α-smooth muscle actin (αSMA), stress fibers, and large focal adhesions (Hinz 2016). Initially, myofibroblasts secrete matrix metalloproteinases (MMPs) that dissolve preexisting ECM and deposit new ECM proteins, mainly collagen I and III, glycoproteins, and proteoglycans (Zwetsloot et al. 2012). The myofibroblasts also synthesize contractile proteins including myosin and αSMA, which orientate themselves into horizontal patterns within the dermis and facilitate wound contraction and remodeling of the new dermal tissue (Fig. 5; Baum and Duffy 2011).

Figure 5.

Figure 5.

The stages of myofibroblast differentiation. Fibroblasts in unwounded skin do not show any stress fibers or focal adhesion but may contain cortical actin. Due to the mechanical tension in the wound bed, fibroblasts first differentiate into proto-myofibroblasts, which contain stress fibers and focal adhesion complexes but generate low contractile force. The presence of TGF-β1 and increased mechanical tension result in further differentiation of proto-fibroblasts to differentiated myofibroblasts. Differentiated myofibroblasts are characterized by the expression of α-smooth muscle actin (αSMA), stress fibers, and super focal adhesions. Differentiated myofibroblasts generate greater contractile force than proto-myofibroblasts, which is reflected by a higher organization of collagen fibers and wound contraction. (ECM) Extracellular matrix.

Myofibroblast stress fibers are composed of γ- and β-cytoplasmic actin and nonmuscle myosin (myosin II). In addition, αSMA is strongly expressed in myofibroblasts as a result of TGF-β signaling (Zent and Guo 2018), leading to contraction and the maturation of super focal adhesions (Hinz et al. 2003; Goffin et al. 2006), which support the transmission of myofibroblast contractile forces to the ECM (Darby et al. 1990; Hinz et al. 2001; Hinz and Gabbiani 2003). In turn, ECM-to-cell mechanical transduction through focal adhesions controls the assembly of stress fibers with α-SMA (Goffin et al. 2006).

As the cell-rich and loose ECM is gradually substituted by ECM with high collagen density (Xue and Jackson 2015), the contraction of the myofibroblast population in granulation tissue formation leads to the collagen-matrix remodeling that results in tissue contracture (Tomasek et al. 2002). This contraction force relies upon myosin II–based contraction along stress fibers, a process that is regulated by Rho signaling, MLCK, and MLC phosphatase (Parizi et al. 2000). Transmission of the force to the surrounding ECM occurs through specialized focal adhesions containing transmembrane integrins (Larsen et al. 2006).

Scar Formation

In a normal healing process, once contracture occurs and tissue heals, myofibroblasts are either deactivated or eliminated from ECM by apoptosis (Wilson et al. 2007; Talele et al. 2015). Prolonged myofibroblast activities can result in accumulation and contraction of collagenous ECM leading to excessive scar formation (Van De Water et al. 2013). Nevertheless, myofibroblasts provide the major contraction force that promotes wound contraction and ECM reorganization. One of the most significant differences between normal tissue and scar tissue is the orientation of the ECM fibrils, which are mainly composed of collagens. Changes in stress of the ECM during remodeling leads to different types of contraction by myofibroblasts (Van De Water et al. 2013). Strong isometric contraction mediated by Rho-ROCK develops slackness in the fibrous collagens, which releases the tension of these fibers. Collagens are subsequently straightened, being pulled in by the myofibroblasts with micro contractions to restore tension, albeit on shorter fibrils (Castella et al. 2010). Random basketweaves of collagen fibers that occur in normal skin, are replaced by large and single-direction collagen fibers running parallel in the skin resulting in the formation of scar tissue (Ehrlich and Krummel 1996; Wolfram et al. 2009). Contractile forces initiated by myofibroblasts are transmitted to the ECM through integrins and develop a strained and more compacted ECM (Larsen et al. 2006). Myofibroblasts also mediate collagen fibrillogenesis by secreting decorin, which integrates into the collagen fibrils assuring uniform spatial fibril arrangement (Zhang et al. 2007). This impact of myofibroblasts results in less flexible dermis, a characteristic of scar formation.

Apoptosis

In the final stage of the remodeling process, macrophages, myofibroblasts, and ECs are eliminated by apoptosis resulting in tissue comprised of a small number of cells and a large amount of ECM proteins, mainly collagen fibers (Velnar et al. 2009; Gonzalez et al. 2016). The actin cytoskeleton is an initiator and mediator of apoptosis with several studies demonstrating its role in triggering apoptosis upstream of caspases through extrinsic and intrinsic pathways (Desouza et al. 2012) and by acting as a substrate for caspase cleavage (Mashima et al. 1999). The destruction of the actin cytoskeleton, through a reduction in actin turnover, induces cell death via apoptotic pathways (Gourlay et al. 2004; Gourlay and Ayscough 2005b), and the depolymerization of actin with cytochalasin D results in the inhibition of Fas-mediated apoptotic signaling (Parlato et al. 2000). The phosphorylation of MLCII with Rho GTPase leads to the contraction of the cortical actin ring and the formation of apoptotic blebs, which is followed by chromatin condensation and nuclear fragmentation (Coleman and Olson 2002). Like bleb formation, apoptotic nuclear disintegration requires ROCK activity and actin-myosin contractile force. At the final stage of apoptosis, the actin cytoskeleton depolymerizes, and the apoptotic bodies are cleared by phagocytosis (Ndozangue-Touriguine et al. 2008). The ABP gelsolin has been shown to inhibit apoptosis by preventing caspase activation and enhancing actin depolymerization (Gourlay and Ayscough 2005a).

TARGETING THE ACTIN CYTOSKELETON TO IMPROVE WOUND HEALING

In vitro and in vivo studies using knockout and overexpression mouse models have provided genetic evidence and biological perspectives regarding the manipulation of actin cytoskeletal proteins emphasizing their vital role in wound healing. A number of these studies is listed in Table 1, demonstrating the mode of manipulation and its outcome on wound healing both in vivo and in vitro. This has focused attention upon identifying cytoskeletal targets that may be manipulated to improve wound outcomes. Following these initial investigations, a number of synthetic peptides, small molecule inhibitors, and neutralizing antibody therapies have been developed for preclinical testing. Some examples are provided in Table 1.

Table 1.

Selected in vivo, ex vivo, and in vitro studies investigating actin cytoskeletal protein effects upon wound-healing processes

Cytoskeleton protein Study type Mode of manipulation Outcome References
Gelsolin In vivo Generation of GSN-null mice Defects in hemostasis and platelet activation, inflammatory response and leukocyte motility, and defects in fibroblast function Witke et al. 1995
Gelsolin In vitro Addition of recombinant gelsolin (rGSN) to mouse fibroblast
GSN siRNA knockdown in human corneal fibroblast
Enhanced migration and increased antioxidant effect,
decreased SMA synthesis
Wittmann et al. 2018; Vaid et al. 2020
Gelsolin Ex vivo Addition of rGSN to mice cornea defect model Elevated cell proliferation and increased wound closure rate Wittmann et al. 2018
Flightless I In vivo Generation of Flii heterozygous and overexpressing mice Improved wound healing, decreased scarring, decreased inflammation, and improved angiogenesis in heterozygous mice Adams et al. 2009; Cameron et al. 2014; Chan et al. 2014; Thomas et al. 2020
Flightless I In vitro Flii siRNA knockdown in human and mouse fibroblast and epithelial cells Increased migration, increased proliferation, and collagen deposition Cowin et al. 2007; Mohammad et al. 2012; Jackson et al. 2020
Tropomyosin In vivo Deletion of tropomyosin gene in mice Elevated cell migration and faster healing response Lees et al. 2013
N-WASP In vivo Conditional knockout of N-WASP in mice Epidermal hyperproliferation in aged mice, increased fibroblast and collagen deposition, and enhanced wound closure Jain et al. 2016
Arp 2/3 In vitro Development of Arp2/3-depleted mouse embryonic fibroblasts Disappearance of lamellipodia and defects in migration Wu et al. 2012
Filamin In vitro Filamin knockdown of filamin by short hairpin RNA in mouse fibroblasts Deformation of collagen matrix, and defect in wound contraction Gurtner and Wong 2015
Filamin In vivo Conditional knockout of filamin in mice Delayed wound closure and deformation of collagen matrix Gurtner and Wong 2015
mDia 1 In vitro Inhibition of cellular mDia1 activity, mDia1 siRNA knockdown in mouse and human epithelial cells Dissociation of leader cells in migration, reduced F-actin level, and impaired wound repair Rao and Zaidel-Bar 2016
Thymosin b4 In vivo Addition of Thymosin b4 to db/db diabetic mice and aged mice Improved dermal wound repair Philp et al. 2003a

Local delivery of ROCK inhibitor Y-27632 to murine excisional wounds delayed healing with reduced formation of αSMA stress fibers but minimal effect on local inflammation or reepithelialization (Tholpady et al. 2014). Conversely, in another study, healing was significantly faster after topical treatment with Y-27632, with a keratinocyte-specific action upon growth and migration (Gandham et al. 2013). The delivery method and dose of ROCK inhibitor was, however, different between the two studies, soaked sponges (20 µmol/L Y-27632) versus daily injection (100 µL of 10−4 M Y-27632) (Tholpady et al. 2014; Turner et al. 2016), suggesting that further investigation of ROCK inhibition in wound healing is warranted. In 14-3-3ζ−/− mice, unrestrained ROCK signaling at wound margins elevated ECM production and reduced ECM remodeling, increasing dermal stiffness and causing rapid wound healing. Inhibition of 14-3-3ζ using a novel pharmacological agent, RB-11, accelerated wound healing twofold, and as patients with chronic nonhealing wounds overexpress 14-3-3ζ, this may be a potential approach for improving wound repair (Kular et al. 2015). The therapeutic infusion of recombinant gelsolin (rGSN) has been investigated for the treatment of large area burns (Rothenbach et al. 2004). Rats with significant burn injuries (40% total body surface area) were treated with rGSN immediately before and after injury, resulting in the decreased permeability of pulmonary microvasculature. Similarly, in a model of acute respiratory distress syndrome that commonly occurs following traumatic injury, treatment with rGSN prevented infiltration of neutrophils in bronchoalveolar fluid, partially preventing the exudative response to injury (Christofidou-Solomidou et al. 2002). Gelsolin family member Flii has also been the target of therapeutic intervention, using siRNA and neutralizing antibodies to prevent its function in mouse and pig models of wound healing (Jackson et al. 2012; Kopecki et al. 2013; Turner et al. 2016, 2017). Injection of porous silicon nanoparticles (pSiNPs) containing Flii siRNA to murine wounds leads to improved healing outcomes (Turner et al. 2016). Similarly, topical application of Flii-neutralizing antibodies, either by intradermal injection to the wound margins or via delivery in a cream formulation, reduced inflammation, lowered the numbers of αSMA-positive myofibroblasts, and reduced scar formation (Jackson et al. 2012; Kopecki et al. 2013; Ruzehaji et al. 2014; Haidari et al. 2017; Turner et al. 2017). The topical treatment of wounds with ABP, thymosin β4, accelerated healing in both diabetic and aged mice, with increased wound contracture and collagen deposition (Philp et al. 2003b) being observed with the pro-healing functions of thymosin β4 confirmed using a seven amino acid synthetic peptide of the actin-binding domain (Philp et al. 2003b).

CONCLUDING REMARKS

While the healing of wounded skin is in itself a gross physiological event, every aspect of this process is exquisitely controlled at a subcellular level by the actin cytoskeleton. Without a functional cytoskeleton, wounds fail to heal making the targeting of these proteins an important and potentially critical avenue for therapeutic development. Although much is known about the integral role these proteins play in cellular responses, targeting individual components may be insufficient to improve the gross and complex physiological responses that are required to treat chronic wounds, burns, or hypertrophic scarring. Further studies are still required to identify how our understanding of the cytoskeleton can be used to successfully improve healing outcomes for complex wounds.

ACKNOWLEDGMENTS

A.J.C. acknowledges the support of the NHMRC Senior Research Fellowship GNT#1102617 for which she is grateful.

Footnotes

Editors: Xing Dai, Sabine Werner, Cheng-Ming Chuong, and Maksim Plikus

Additional Perspectives on Wound Healing: From Bench to Bedside available at www.cshperspectives.org

REFERENCES

  1. Abraham S, Yeo M, Montero-Balaguer M, Paterson H, Dejana E, Marshall CJ, Mavria G. 2009. VE-cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation. Curr Biol 19: 668–674. 10.1016/j.cub.2009.02.057 [DOI] [PubMed] [Google Scholar]
  2. Abreu-Blanco M, Watts JJ, Verboon JM, Parkhurst S. 2012. Cytoskeleton responses in wound repair. Cell Mol Life Sci 69: 2469–2483. 10.1007/s00018-012-0928-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Adams DH, Ruzehaji N, Strudwick XL, Greenwood JE, Campbell HD, Arkell R, Cowin AJ. 2009. Attenuation of Flightless I, an actin-remodelling protein, improves burn injury repair via modulation of transforming growth factor (TGF)-β1 and TGF-β3. Br J Dermatol 161: 326–336. 10.1111/j.1365-2133.2009.09296.x [DOI] [PubMed] [Google Scholar]
  4. Adzick NS. 1992. Wound healing: biochemical and clinical aspects. Ann Surg 216: 613. [Google Scholar]
  5. Amano M, Nakayama M, Kaibuchi K. 2010. Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken) 67: 545–554. 10.1002/cm.20472 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Anderson SI, Hotchin NA, Nash GB. 2000. Role of the cytoskeleton in rapid activation of CD11b/CD18 function and its subsequent downregulation in neutrophils. J Cell Sci 113: 2737–2745. 10.1242/jcs.113.15.2737 [DOI] [PubMed] [Google Scholar]
  7. Aragona M, Dekoninck S, Rulands S, Lenglez S, Mascré G, Simons BD, Blanpain C. 2017. Defining stem cell dynamics and migration during wound healing in mouse skin epidermis. Nat Commun 8: 14684. 10.1038/ncomms14684 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Arora PD, Wang Y, Bresnick A, Janmey PA, McCulloch CA. 2015. Flightless I interacts with NMMIIA to promote cell extension formation, which enables collagen remodeling. Mol Biol Cell 26: 2279–2297. 10.1091/mbc.E14-11-1536 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Badmalia MD, Singh S, Garg R, Ashish. 2017. Visualizing temperature mediated activation of gelsolin and its deactivation by Pip2: a Saxs based study. Sci Rep 7: 4670–4670. 10.1038/s41598-017-04975-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bainbridge P. 2013. Wound healing and the role of fibroblasts. J Wound Care 22: 410–412. [DOI] [PubMed] [Google Scholar]
  11. Bao Y, Kake T, Hanashima A, Nomiya Y, Kubokawa K, Kimura S. 2012. Actin capping proteins, CapZ (β-actinin) and tropomodulin in amphioxus striated muscle. Gene 510: 78–86. 10.1016/j.gene.2012.07.081 [DOI] [PubMed] [Google Scholar]
  12. Barreiro O, Yáñez-Mó M, Serrador JM, Montoya MC, Vicente-Manzanares M, Tejedor R, Furthmayr H, Sánchez-Madrid F. 2002. Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Cell Biol 157: 1233–1245. 10.1083/jcb.200112126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Baum J, Duffy HS. 2011. Fibroblasts and myofibroblasts: what are we talking about? J Cardiovasc Pharmacol 57: 376–379. 10.1097/FJC.0b013e3182116e39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bearer EL, Prakash JM, Li Z. 2002. Actin dynamics in platelets. Int Rev Cytol 217: 137–182. 10.1016/S0074-7696(02)17014-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Beningo KA, Hamao K, Dembo M, Wang YL, Hosoya H. 2006. Traction forces of fibroblasts are regulated by the Rho-dependent kinase but not by the myosin light chain kinase. Arch Biochem Biophys 456: 224–231. 10.1016/j.abb.2006.09.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Burtnick LD, Koepf EK, Grimes J, Jones EY, Stuart DI, McLaughlin PJ, Robinson RC. 1997. The crystal structure of plasma gelsolin: implications for actin severing, capping, and nucleation. Cell 90: 661–670. 10.1016/S0092-8674(00)80527-9 [DOI] [PubMed] [Google Scholar]
  17. Cameron AM, Adams DH, Greenwood JE, Anderson PJ, Cowin AJ. 2014. A novel murine model of hypertrophic scarring using subcutaneous infusion of bleomycin. Plast Reconstr Surg 133: 69–78. 10.1097/01.prs.0000436821.26709.a7 [DOI] [PubMed] [Google Scholar]
  18. Carman CV, Springer TA. 2004. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol 167: 377–388. 10.1083/jcb.200404129 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Castella LF, Buscemi L, Godbout C, Meister JJ, Hinz B. 2010. A new lock-step mechanism of matrix remodelling based on subcellular contractile events. J Cell Sci 123: 1751–1760. 10.1242/jcs.066795 [DOI] [PubMed] [Google Scholar]
  20. Cerecedo D. 2013. Platelet cytoskeleton and its hemostatic role. Blood Coagul Fibrinolysis 24: 798–808. 10.1097/MBC.0b013e328364c379 [DOI] [PubMed] [Google Scholar]
  21. Chan H, Kopecki Z, Waters JM, Powell BC, Arkell RM, Cowin AJ. 2014. Cytoskeletal protein flightless I differentially affects TGF-β isoform expression in both in vitro and in vivo wound models. Wound Practice Res J Australian Wound Manag Assoc 22: 169–181. [Google Scholar]
  22. Cheffings TH, Burroughs Nigel J, Balasubramanian Mohan K. 2016. Actomyosin ring formation and tension generation in eukaryotic cytokinesis. Curr Biol 26: R719–R737. 10.1016/j.cub.2016.06.071 [DOI] [PubMed] [Google Scholar]
  23. Chen W, Xia P, Wang H, Tu J, Liang X, Zhang X, Li L. 2019. The endothelial tip-stalk cell selection and shuffling during angiogenesis. J Cell Commun Signal 13: 291–301. 10.1007/s12079-019-00511-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Chesarone MA, Goode BL. 2009. Actin nucleation and elongation factors: mechanisms and interplay. Curr Opin Cell Biol 21: 28–37. 10.1016/j.ceb.2008.12.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Christofidou-Solomidou M, Scherpereel A, Solomides CC, Christie JD, Stossel TP, Goelz S, DiNubile MJ. 2002. Recombinant plasma gelsolin diminishes the acute inflammatory response to hyperoxia in mice. J Investig Med 50: 54–60. 10.2310/6650.2002.33518 [DOI] [PubMed] [Google Scholar]
  26. Coleman ML, Olson MF. 2002. Rho GTPase signalling pathways in the morphological changes associated with apoptosis. Cell Death Differ 9: 493–504. 10.1038/sj.cdd.4400987 [DOI] [PubMed] [Google Scholar]
  27. Cook-Mills JM, Johnson JD, Deem TL, Ochi A, Wang L, Zheng Y. 2004. Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activity. Biochem J 378: 539–547. 10.1042/bj20030794 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Cowin AJ, Hatzirodos N, Teusner JT, Belford DA. 2003. Differential effect of wounding on actin and its associated proteins, paxillin and gelsolin, in fetal skin explants. J Invest Dermatol 120: 1118–1129. 10.1046/j.1523-1747.2003.12231.x [DOI] [PubMed] [Google Scholar]
  29. Cowin AJ, Adams DH, Strudwick XL, Chan H, Hooper JA, Sander GR, Rayner TE, Matthaei KI, Powell BC, Campbell HD. 2007. Flightless I deficiency enhances wound repair by increasing cell migration and proliferation. J Pathol 211: 572–581. 10.1002/path.2143 [DOI] [PubMed] [Google Scholar]
  30. Crowley MT, Costello PS, Fitzer-Attas CJ, Turner M, Meng F, Lowell C, Tybulewicz VL, DeFranco AL. 1997. A critical role for Syk in signal transduction and phagocytosis mediated by Fcγ receptors on macrophages. J Exp Med 186: 1027–1039. 10.1084/jem.186.7.1027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Dahl B, Schiødt FV, Ott P, Wians F, Lee WM, Balko J, O'Keefe GE. 2003. Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit Care Med 31: 152–156. 10.1097/00003246-200301000-00024 [DOI] [PubMed] [Google Scholar]
  32. Darby I, Skalli O, Gabbiani G. 1990. α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63: 21–29. [PubMed] [Google Scholar]
  33. Dart AE, Donnelly SK, Holden DW, Way M, Caron E. 2012. Nck and Cdc42 co-operate to recruit N-WASP to promote FcγR-mediated phagocytosis. J Cell Sci 125: 2825–2830. [DOI] [PubMed] [Google Scholar]
  34. Davidson AJ, Wood W. 2020. Macrophages use distinct actin regulators to switch engulfment strategies and ensure phagocytic plasticity in vivo. Cell Rep 31: 107692. 10.1016/j.celrep.2020.107692 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Davy DA, Campbell HD, Fountain S, de Jong D, Crouch MF. 2001. The flightless I protein colocalizes with actin- and microtubule-based structures in motile Swiss 3T3 fibroblasts: evidence for the involvement of PI 3-kinase and Ras-related small GTPases. J Cell Sci 114: 549–562. 10.1242/jcs.114.3.549 [DOI] [PubMed] [Google Scholar]
  36. Delanghe JR, Speeckaert R, Speeckaert MM. 2015. Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best Pract Res Clin Endocrinol Metab 29: 773–786. 10.1016/j.beem.2015.06.006 [DOI] [PubMed] [Google Scholar]
  37. Delon I, Brown NH. 2007. Integrins and the actin cytoskeleton. Curr Opin Cell Biol 19: 43–50. 10.1016/j.ceb.2006.12.013 [DOI] [PubMed] [Google Scholar]
  38. DeMali KA, Wennerberg K, Burridge K. 2003. Integrin signaling to the actin cytoskeleton. Curr Opin Cell Biol 15: 572–582. 10.1016/S0955-0674(03)00109-1 [DOI] [PubMed] [Google Scholar]
  39. desJardins-Park HE, Foster DS, Longaker MT. 2018. Fibroblasts and wound healing: an update. Regen Med 13: 491–495. 10.2217/rme-2018-0073 [DOI] [PubMed] [Google Scholar]
  40. Desouza M, Gunning PW, Stehn JR. 2012. The actin cytoskeleton as a sensor and mediator of apoptosis. Bioarchitecture 2: 75–87. 10.4161/bioa.20975 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Dwir O, Kansas GS, Alon R. 2001. Cytoplasmic anchorage of L-selectin controls leukocyte capture and rolling by increasing the mechanical stability of the selectin tether. J Cell Biol 155: 145–156. 10.1083/jcb.200103042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Edwards M, Zwolak A, Schafer DA, Sept D, Dominguez R, Cooper JA. 2014. Capping protein regulators fine-tune actin assembly dynamics. Nat Rev Mol Cell Biol 15: 677–689. 10.1038/nrm3869 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Egile C, Rouiller I, Xu XP, Volkmann N, Li R, Hanein D. 2005. Mechanism of filament nucleation and branch stability revealed by the structure of the Arp2/3 complex at actin branch junctions. PLoS Biol 3: e383. 10.1371/journal.pbio.0030383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Ehrlich HP, Krummel TM. 1996. Regulation of wound healing from a connective tissue perspective. Wound Repair Regen 4: 203–210. 10.1046/j.1524-475X.1996.40206.x [DOI] [PubMed] [Google Scholar]
  45. Escolar G, Krumwiede M, White JG. 1986. Organization of the actin cytoskeleton of resting and activated platelets in suspension. Am J Pathol 123: 86–94. [PMC free article] [PubMed] [Google Scholar]
  46. Fletcher DA, Mullins RD. 2010. Cell mechanics and the cytoskeleton. Nature 463: 485–492. 10.1038/nature08908 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Gandham VD, Maddala RL, Rao V, Jin JY, Epstein DL, Hall RP, Zhang JY. 2013. Effects of Y27632 on keratinocyte procurement and wound healing. Clin Exp Dermatol 38: 782–786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Gerien KS, Wu JQ. 2018. Molecular mechanisms of contractile-ring constriction and membrane trafficking in cytokinesis. Biophys Rev 10: 1649–1666. 10.1007/s12551-018-0479-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Glotzer M. 2009. The 3Ms of central spindle assembly: microtubules, motors and MAPs. Nat Rev Mol Cell Biol 10: 9–20. 10.1038/nrm2609 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Goffin JM, Pittet P, Csucs G, Lussi JW, Meister JJ, Hinz B. 2006. Focal adhesion size controls tension-dependent recruitment of α-smooth muscle actin to stress fibers. J Cell Biol 172: 259–268. 10.1083/jcb.200506179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Goldschmidt-Clermont PJ, Furman MI, Wachsstock D, Safer D, Nachmias VT, Pollard TD. 1992. The control of actin nucleotide exchange by thymosin β4 and profilin. A potential regulatory mechanism for actin polymerization in cells. Mol Biol Cell 3: 1015–1024. 10.1091/mbc.3.9.1015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Gonzalez ACDO, Costa TF, Andrade ZDA, Medrado ARAP. 2016. Wound healing—a literature review. An Bras Dermatol 91: 614–620. 10.1590/abd1806-4841.20164741 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Goode BL, Eck MJ. 2007. Mechanism and function of formins in the control of actin assembly. Annu Rev Biochem 76: 593–627. 10.1146/annurev.biochem.75.103004.142647 [DOI] [PubMed] [Google Scholar]
  54. Goodson HV, Jonasson EM. 2018. Microtubules and microtubule-associated proteins. Cold Spring Harb Perspect Biol 10: a022608. 10.1101/cshperspect.a022608 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Goshima M, Kariya K, Yamawaki-Kataoka Y, Okada T, Shibatohge M, Shima F, Fujimoto E, Kataoka T. 1999. Characterization of a novel Ras-binding protein Ce-FLI-1 comprising leucine-rich repeats and gelsolin-like domains. Biochem Biophys Res Commun 257: 111–116. 10.1006/bbrc.1999.0420 [DOI] [PubMed] [Google Scholar]
  56. Gourlay CW, Ayscough KR. 2005a. The actin cytoskeleton: a key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol 6: 583–589. 10.1038/nrm1682 [DOI] [PubMed] [Google Scholar]
  57. Gourlay CW, Ayscough KR. 2005b. Identification of an upstream regulatory pathway controlling actin-mediated apoptosis in yeast. J Cell Sci 118: 2119–2132. 10.1242/jcs.02337 [DOI] [PubMed] [Google Scholar]
  58. Gourlay CW, Carpp LN, Timpson P, Winder SJ, Ayscough KR. 2004. A role for the actin cytoskeleton in cell death and aging in yeast. J Cell Biol 164: 803–809. 10.1083/jcb.200310148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Gov NS. 2009. Traction forces during collective cell motion. HFSP J 3: 223–227. 10.2976/1.3185785 [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Gremm D, Wegner A. 2000. Gelsolin as a calcium-regulated actin filament-capping protein. Eur J Biochem 267: 4339–4345. 10.1046/j.1432-1327.2000.01463.x [DOI] [PubMed] [Google Scholar]
  61. Grinnell F, Baxter CR, Zhu M, Yin HL. 1993. Detection of the actin scavenger system in burn wound fluid. Wound Repair Regen 1: 236–243. 10.1046/j.1524-475X.1993.10409.x [DOI] [PubMed] [Google Scholar]
  62. Gross SR. 2013. Actin binding proteins: their ups and downs in metastatic life. Cell Adh Migr 7: 199–213. 10.4161/cam.23176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Gurtner GC, Wong VW. 2015. Filamin A mediates wound closure by promoting elastic deformation and maintenance of tension in the collagen matrix. J Invest Dermatol 135: 2569–2571. 10.1038/jid.2015.327 [DOI] [PubMed] [Google Scholar]
  64. Haddad JG, Harper KD, Guoth M, Pietra GG, Sanger JW. 1990. Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci 87: 1381–1385. 10.1073/pnas.87.4.1381 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Haidari H, Zhang Q, Melville E, Kopecki Z, Song Y, Cowin AJ, Garg S. 2017. Development of topical delivery systems for flightless neutralizing antibody. J Pharm Sci 106: 1795–1804. 10.1016/j.xphs.2017.03.012 [DOI] [PubMed] [Google Scholar]
  66. Hall A. 2005. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 33: 891–895. 10.1042/BST0330891 [DOI] [PubMed] [Google Scholar]
  67. Hamill KJ, Hopkinson SB, Skalli O, Jones JCR. 2013. Actinin-4 in keratinocytes regulates motility via an effect on lamellipodia stability and matrix adhesions. FASEB J 27: 546–556. 10.1096/fj.12-217406 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Harris AK, Stopak D, Wild P. 1981. Fibroblast traction as a mechanism for collagen morphogenesis. Nature 290: 249–251. 10.1038/290249a0 [DOI] [PubMed] [Google Scholar]
  69. Higashi T, Ikeda T, Murakami T, Shirakawa R, Kawato M, Okawa K, Furuse M, Kimura T, Kita T, Horiuchi H. 2010. Flightless-I (Fli-I) regulates the actin assembly activity of diaphanous-related formins (DRFs) Daam1 and mDia1 in cooperation with active Rho GTPase. J Biol Chem 285: 16231–16238. 10.1074/jbc.M109.079236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Hinz B. 2016. Myofibroblasts. Exp Eye Res 142: 56–70. 10.1016/j.exer.2015.07.009 [DOI] [PubMed] [Google Scholar]
  71. Hinz B, Gabbiani G. 2003. Mechanisms of force generation and transmission by myofibroblasts. Curr Opin Biotechnol 14: 538–546. 10.1016/j.copbio.2003.08.006 [DOI] [PubMed] [Google Scholar]
  72. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. 2001. α-Smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12: 2730–2741. 10.1091/mbc.12.9.2730 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Hinz B, Dugina V, Ballestrem C, Wehrle-Haller B, Chaponnier C. 2003. α-Smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol Biol Cell 14: 2508–2519. 10.1091/mbc.e02-11-0729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Hohmann T, Dehghani F. 2019. The cytoskeleton—a complex interacting meshwork. Cells 8: 362. 10.3390/cells8040362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Horio T, Murata T. 2014. The role of dynamic instability in microtubule organization. Front Plant Sci 5: 511. 10.3389/fpls.2014.00511 [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Hou S, Isaji T, Hang Q, Im S, Fukuda T, Gu J. 2016. Distinct effects of β1 integrin on cell proliferation and cellular signaling in MDA-MB-231 breast cancer cells. Sci Rep 6: 18430. 10.1038/srep18430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Huveneers S, Danen EHJ. 2009. Adhesion signaling—crosstalk between integrins, Src and Rho. J Cell Sci 122: 1059–1069. 10.1242/jcs.039446 [DOI] [PubMed] [Google Scholar]
  78. Infante E, Ridley AJ. 2013. Roles of Rho GTPases in leucocyte and leukaemia cell transendothelial migration. Philos Trans R Soc Lond B Biol Sci 368: 20130013. 10.1098/rstb.2013.0013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Innocenti M. 2018. New insights into the formation and the function of lamellipodia and ruffles in mesenchymal cell migration. Cell Adh Migr 12: 401–416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Jacinto A, Martinez-Arias A, Martin P. 2001. Mechanisms of epithelial fusion and repair. Nat Cell Biol 3: E117–E123. 10.1038/35074643 [DOI] [PubMed] [Google Scholar]
  81. Jackson JE, Kopecki Z, Adams DH, Cowin AJ. 2012. Flii neutralizing antibodies improve wound healing in porcine preclinical studies. Wound Repair Regen 20: 523–536. [DOI] [PubMed] [Google Scholar]
  82. Jackson JE, Kopecki Z, Anderson PJ, Cowin AJ. 2020. In vitro analysis of the effect of Flightless I on murine tenocyte cellular functions. J Orthop Surg Res 15: 170. 10.1186/s13018-020-01692-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Jain N, Kalailingam P, Tan KW, Tan HB, Sng MK, Chan JSK, Tan NS, Thanabalu T. 2016. Conditional knockout of N-WASP in mouse fibroblast caused keratinocyte hyper proliferation and enhanced wound closure. Sci Rep 6: 38109. 10.1038/srep38109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Jozic I, Abujamra BA, Elliott MH, Wikramanayake TC, Marjanovic J, Stone RC, Head CR, Pastar I, Kirsner RS, Andreopoulos FM, et al. 2021. Glucocorticoid-mediated induction of caveolin-1 disrupts cytoskeletal organization, inhibits cell migration and re-epithelialization of non-healing wounds. Commun Biol 4: 757. 10.1038/s42003-021-02298-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Kew RR. 2019. The vitamin D binding protein and inflammatory injury: a mediator or sentinel of tissue damage? Front Endocrinol (Lausanne) 10: 470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Klein MG, Shi W, Ramagopal U, Tseng Y, Wirtz D, Kovar DR, Staiger CJ, Almo SC. 2004. Structure of the actin crosslinking core of fimbrin. Structure 12: 999–1013. 10.1016/j.str.2004.04.010 [DOI] [PubMed] [Google Scholar]
  87. Kopecki Z, Cowin AJ. 2008. Flightless I: an actin-remodelling protein and an important negative regulator of wound repair. Int J Biochem Cell Biol 40: 1415–1419. 10.1016/j.biocel.2007.04.011 [DOI] [PubMed] [Google Scholar]
  88. Kopecki Z, Arkell R, Powell BC, Cowin AJ. 2009. Flightless I regulates hemidesmosome formation and integrin-mediated cellular adhesion and migration during wound repair. J Invest Dermatol 129: 2031–2045. 10.1038/jid.2008.461 [DOI] [PubMed] [Google Scholar]
  89. Kopecki Z, O'Neill GM, Arkell RM, Cowin AJ. 2011. Regulation of focal adhesions by Flightless I involves inhibition of paxillin phosphorylation via a Rac1-dependent pathway. J Invest Dermatol 131: 1450–1459. 10.1038/jid.2011.69 [DOI] [PubMed] [Google Scholar]
  90. Kopecki Z, Ruzehaji N, Turner C, Iwata H, Ludwig RJ, Zillikens D, Murrell DF, Cowin AJ. 2013. Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita. J Invest Dermatol 133: 1008–1016. 10.1038/jid.2012.457 [DOI] [PubMed] [Google Scholar]
  91. Kühn S, Geyer M. 2014. Formins as effector proteins of Rho GTPases. Small GTPases 5: e29513–e29513. 10.4161/sgtp.29513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Kular J, Scheer Kaitlin G, Pyne Natasha T, Allam Amr H, Pollard Anthony N, Magenau A, Wright Rebecca L, Kolesnikoff N, Moretti Paul A, Wullkopf L, et al. 2015. A negative regulatory mechanism involving 14-3-3ζ limits signaling downstream of ROCK to regulate tissue stiffness in epidermal homeostasis. Dev Cell 35: 759–774. 10.1016/j.devcel.2015.11.026 [DOI] [PubMed] [Google Scholar]
  93. Lamalice L, Boeuf FL, Huot J. 2007. Endothelial cell migration during angiogenesis. Circ Res 100: 782–794. 10.1161/01.RES.0000259593.07661.1e [DOI] [PubMed] [Google Scholar]
  94. Lammers M, Meyer S, Kühlmann D, Wittinghofer A. 2008. Specificity of interactions between mDia isoforms and Rho proteins. J Biol Chem 283: 35236–35246. 10.1074/jbc.M805634200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Larsen M, Artym VV, Green JA, Yamada KM. 2006. The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol 18: 463–471. 10.1016/j.ceb.2006.08.009 [DOI] [PubMed] [Google Scholar]
  96. Laurens N, Koolwijk P, De Maat MPM. 2006. Fibrin structure and wound healing. J Thromb Haemost 4: 932–939. 10.1111/j.1538-7836.2006.01861.x [DOI] [PubMed] [Google Scholar]
  97. Lees JG, Ching YW, Adams DH, Bach CTT, Samuel MS, Kee AJ, Hardeman EC, Gunning P, Cowin AJ, O'Neill GM. 2013. Tropomyosin regulates cell migration during skin wound healing. J Invest Dermatol 133: 1330–1339. 10.1038/jid.2012.489 [DOI] [PubMed] [Google Scholar]
  98. Li GH, Arora PD, Chen Y, McCulloch CA, Liu P. 2012. Multifunctional roles of gelsolin in health and diseases. Med Res Rev 32: 999–1025. 10.1002/med.20231 [DOI] [PubMed] [Google Scholar]
  99. Lind SE, Smith DB, Janmey PA, Stossel TP. 1986. Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J Clin Invest 78: 736–742. 10.1172/JCI112634 [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Liu YT, Yin HL. 1998. Identification of the binding partners for flightless I, A novel protein bridging the leucine-rich repeat and the gelsolin superfamilies. J Biol Chem 273: 7920–7927. 10.1074/jbc.273.14.7920 [DOI] [PubMed] [Google Scholar]
  101. Marei H, Carpy A, Woroniuk A, Vennin C, White G, Timpson P, Macek B, Malliri A. 2016. Differential Rac1 signalling by guanine nucleotide exchange factors implicates FLII in regulating Rac1-driven cell migration. Nat Commun 7: 10664. 10.1038/ncomms10664 [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Martin P, Lewis J. 1992. Actin cables and epidermal movement in embryonic wound healing. Nature 360: 179–183. 10.1038/360179a0 [DOI] [PubMed] [Google Scholar]
  103. Mashima T, Naito M, Tsuruo T. 1999. Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene 18: 2423–2430. 10.1038/sj.onc.1202558 [DOI] [PubMed] [Google Scholar]
  104. Matsumura F. 2005. Regulation of myosin II during cytokinesis in higher eukaryotes. Trends Cell Biol 15: 371–377. 10.1016/j.tcb.2005.05.004 [DOI] [PubMed] [Google Scholar]
  105. Mazur AJ, Gremm D, Dansranjavin T, Litwin M, Jockusch BM, Wegner A, Weeds AG, Mannherz HG. 2010. Modulation of actin filament dynamics by actin-binding proteins residing in lamellipodia. Eur J Cell Biol 89: 402–413. 10.1016/j.ejcb.2009.10.017 [DOI] [PubMed] [Google Scholar]
  106. Millard TH, Martin P. 2008. Dynamic analysis of filopodial interactions during the zippering phase of Drosophila dorsal closure. Development 135: 621–626. 10.1242/dev.014001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Mohammad I, Arora PD, Naghibzadeh Y, Wang Y, Li J, Mascarenhas W, Janmey PA, Dawson JF, McCulloch CA. 2012. Flightless I is a focal adhesion-associated actin-capping protein that regulates cell migration. FASEB J 26: 3260–3272. 10.1096/fj.11-202051 [DOI] [PubMed] [Google Scholar]
  108. Mounzer KC, Moncure M, Smith YR, Dinubile MJ. 1999. Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am J Respir Crit Care Med 160: 1673–1681. 10.1164/ajrccm.160.5.9807137 [DOI] [PubMed] [Google Scholar]
  109. Muller WA. 2013. Getting leukocytes to the site of inflammation. Vet Pathol 50: 7–22. 10.1177/0300985812469883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Nag S, Larsson M, Robinson RC, Burtnick LD. 2013. Gelsolin: the tail of a molecular gymnast. Cytoskeleton 70: 360–384. 10.1002/cm.21117 [DOI] [PubMed] [Google Scholar]
  111. Ndozangue-Touriguine O, Hamelin J, Bréard J. 2008. Cytoskeleton and apoptosis. Biochem Pharmacol 76: 11–18. 10.1016/j.bcp.2008.03.016 [DOI] [PubMed] [Google Scholar]
  112. Noordstra I, Akhmanova A. 2017. Linking cortical microtubule attachment and exocytosis. F1000Res 6: 469. 10.12688/f1000research.10729.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Norton KA, Popel AS. 2016. Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis. Sci Rep 6: 36992–36992. 10.1038/srep36992 [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Papadopulos A. 2017. Membrane shaping by actin and myosin during regulated exocytosis. Mol Cell Neurosci 84: 93–99. 10.1016/j.mcn.2017.05.006 [DOI] [PubMed] [Google Scholar]
  115. Parizi M, Howard EW, Tomasek JJ. 2000. Regulation of LPA-promoted myofibroblast contraction: role of Rho, myosin light chain kinase, and myosin light chain phosphatase. Exp Cell Res 254: 210–220. 10.1006/excr.1999.4754 [DOI] [PubMed] [Google Scholar]
  116. Parlato S, Giammarioli AM, Logozzi M, Lozupone F, Matarrese P, Luciani F, Falchi M, Malorni W, Fais S. 2000. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J 19: 5123–5134. 10.1093/emboj/19.19.5123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Pavlov D, Muhlrad A, Cooper J, Wear M, Reisler E. 2007. Actin filament severing by cofilin. J Mol Biol 365: 1350–1358. 10.1016/j.jmb.2006.10.102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Phillips GN Jr, Lattman EE, Cummins P, Lee KY, Cohen C. 1979. Crystal structure and molecular interactions of tropomyosin. Nature 278: 413–417. 10.1038/278413a0 [DOI] [PubMed] [Google Scholar]
  119. Philp D, Badamchian M, Scheremeta B, Nguyen M, Goldstein AL, Kleinman HK. 2003a. Thymosin β4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen 11: 19–24. 10.1046/j.1524-475X.2003.11105.x [DOI] [PubMed] [Google Scholar]
  120. Philp D, Badamchian M, Scheremeta B, Nguyen M, Goldstein AL, Kleinman HK. 2003b. Thymosin β4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen 11: 19–24. 10.1046/j.1524-475X.2003.11105.x [DOI] [PubMed] [Google Scholar]
  121. Pires R, Felix S, Delcea M. 2016. The architecture of neutrophil extracellular traps investigated by atomic force microscopy. Nanoscale 8: 14193–14202. 10.1039/C6NR03416K [DOI] [PubMed] [Google Scholar]
  122. Pollard TD. 2016. Actin and actin-binding proteins. Cold Spring Harb Perspect Biol 8: a018226. 10.1101/cshperspect.a018226 [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Potente M, Gerhardt H, Carmeliet P. 2011. Basic and therapeutic aspects of angiogenesis. Cell 146: 873–887. 10.1016/j.cell.2011.08.039 [DOI] [PubMed] [Google Scholar]
  124. Provenzano PP, Keely PJ. 2011. Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J Cell Sci 124: 1195–1205. 10.1242/jcs.067009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Pruitt K, Der CJ. 2001. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett 171: 1–10. 10.1016/S0304-3835(01)00528-6 [DOI] [PubMed] [Google Scholar]
  126. Pugh CW, Ratcliffe PJ. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9: 677–684. 10.1038/nm0603-677 [DOI] [PubMed] [Google Scholar]
  127. Raftopoulou M, Hall A. 2004. Cell migration: Rho GTPases lead the way. Dev Biol 265: 23–32. 10.1016/j.ydbio.2003.06.003 [DOI] [PubMed] [Google Scholar]
  128. Rao MV, Zaidel-Bar R. 2016. Formin-mediated actin polymerization at cell–cell junctions stabilizes E-cadherin and maintains monolayer integrity during wound repair. Mol Biol Cell 27: 2844–2856. 10.1091/mbc.e16-06-0429 [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Reglero-Real N, Colom B, Bodkin JV, Nourshargh S. 2016. Endothelial cell junctional adhesion molecules: role and regulation of expression in inflammation. Arterioscler Thromb Vasc Biol 36: 2048–2057. 10.1161/ATVBAHA.116.307610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Ren C, Yuan Q, Braun M, Zhang X, Petri B, Zhang J, Kim D, Guez-Haddad J, Xue W, Pan W, et al. 2019. Leukocyte cytoskeleton polarization is initiated by plasma membrane curvature from cell attachment. Dev Cell 49: 206–219.e7. 10.1016/j.devcel.2019.02.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Ridley AJ. 2015. Rho GTPase signalling in cell migration. Curr Opin Cell Biol 36: 103–112. 10.1016/j.ceb.2015.08.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Rodnick-Smith M, Luan Q, Liu SL, Nolen BJ. 2016. Role and structural mechanism of WASP-triggered conformational changes in branched actin filament nucleation by Arp2/3 complex. Proc Natl Acad Sci 113: E3834–E3843. 10.1073/pnas.1517798113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Rothenbach PA, Dahl B, Schwartz JJ, O'Keefe GE, Yamamoto M, Lee WM, Horton JW, Yin HL, Turnage RH. 2004. Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol (1985) 96: 25–31. 10.1152/japplphysiol.01074.2002 [DOI] [PubMed] [Google Scholar]
  134. Ruzehaji N, Kopecki Z, Melville E, Appleby SL, Bonder CS, Arkell RM, Fitridge R, Cowin AJ. 2014. Attenuation of flightless I improves wound healing and enhances angiogenesis in a murine model of type 1 diabetes. Diabetologia 57: 402–412. 10.1007/s00125-013-3107-6 [DOI] [PubMed] [Google Scholar]
  135. Salbreux G, Prost J, Joanny J. 2009. Hydrodynamics of cellular cortical flows and the formation of contractile rings. Phys Rev Lett 103: 058102. 10.1103/PhysRevLett.103.058102 [DOI] [PubMed] [Google Scholar]
  136. Sanghvi-Shah R, Weber G. 2017. Intermediate filaments at the junction of mechanotransduction, migration, and development. Front Cell Dev Biol 5: 81. 10.3389/fcell.2017.00081 [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Sauteur L, Krudewig A, Herwig L, Ehrenfeuchter N, Lenard A, Affolter M, Belting HG. 2014. Cdh5/VE-cadherin promotes endothelial cell interface elongation via cortical actin polymerization during angiogenic sprouting. Cell Rep 9: 504–513. 10.1016/j.celrep.2014.09.024 [DOI] [PubMed] [Google Scholar]
  138. Schnoor M. 2015. Endothelial actin-binding proteins and actin dynamics in leukocyte transendothelial migration. J Immunol 194: 3535–3541. 10.4049/jimmunol.1403250 [DOI] [PubMed] [Google Scholar]
  139. Schwartz MA, Assoian RK. 2001. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci 114: 2553–2560. 10.1242/jcs.114.14.2553 [DOI] [PubMed] [Google Scholar]
  140. Schwartz MA, Shattil SJ. 2000. Signaling networks linking integrins and Rho family GTPases. Trends Biochem Sci 25: 388–391. 10.1016/S0968-0004(00)01605-4 [DOI] [PubMed] [Google Scholar]
  141. Serrander L, Skarman P, Rasmussen B, Witke W, Lew DP, Krause KH, Stendahl O, Nüße O. 2000. Selective inhibition of IgG-mediated phagocytosis in gelsolin-deficient murine neutrophils. J Immunol 165: 2451–2457. 10.4049/jimmunol.165.5.2451 [DOI] [PubMed] [Google Scholar]
  142. Shaw TJ, Martin P. 2009. Wound repair at a glance. J Cell Sci 122: 3209–3213. 10.1242/jcs.031187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Shin EK, Park H, Noh JY, Lim KM, Chung JH. 2017. Platelet shape changes and cytoskeleton dynamics as novel therapeutic targets for anti-thrombotic drugs. Biomol Ther (Seoul) 25: 223–230. 10.4062/biomolther.2016.138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin H, Hayoz D. 2004. Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci 61: 2614–2623. 10.1007/s00018-004-4225-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, Schleicher M, Shapiro SS. 2001. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol 2: 138–145. 10.1038/35052082 [DOI] [PubMed] [Google Scholar]
  146. Stradal TEB, Rottner K, Disanza A, Confalonieri S, Innocenti M, Scita G. 2004. Regulation of actin dynamics by WASP and WAVE family proteins. Trends Cell Biol 14: 303–311. 10.1016/j.tcb.2004.04.007 [DOI] [PubMed] [Google Scholar]
  147. Strudwick XL, Cowin AJ. 2020. Multifunctional roles of the actin-binding protein Flightless I in inflammation, cancer and wound healing. Front Cell Dev Biol 8: 603508. 10.3389/fcell.2020.603508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Szymborska A, Gerhardt H. 2018. Hold me, but not too tight—endothelial cell–cell junctions in angiogenesis. Cold Spring Harb Perspect Biol 10: a029223. 10.1101/cshperspect.a029223 [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Talele Nilesh P, Fradette J, Davies John E, Kapus A, Hinz B. 2015. Expression of α-smooth muscle actin determines the fate of mesenchymal stromal cells. Stem Cell Rep 4: 1016–1030. 10.1016/j.stemcr.2015.05.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Thiam HR, Wong SL, Qiu R, Kittisopikul M, Vahabikashi A, Goldman AE, Goldman RD, Wagner DD, Waterman CM. 2020a. NETosis proceeds by cytoskeleton and endomembrane disassembly and PAD4-mediated chromatin decondensation and nuclear envelope rupture. Proc Natl Acad Sci 117: 7326–7337. 10.1073/pnas.1909546117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Thiam HR, Wong SL, Wagner DD, Waterman CM. 2020b. Cellular mechanisms of NETosis. Annu Rev Cell Dev Biol 36: 191–218. 10.1146/annurev-cellbio-020520-111016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Tholpady SS, DeGeorge BR Jr, Campbell CA. 2014. The effect of local rho-kinase inhibition on murine wound healing. Ann Plast Surg 72: S213–S219. 10.1097/SAP.0000000000000150 [DOI] [PubMed] [Google Scholar]
  153. Thomas HM, Ahangar P, Hofma BR, Strudwick XL, Fitridge R, Mills SJ, Cowin AJ. 2020. Attenuation of Flightless I increases human pericyte proliferation, migration and angiogenic functions and improves healing in murine diabetic wounds. Int J Mol Sci 21: 5599. 10.3390/ijms21165599 [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. 2002. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349–363. 10.1038/nrm809 [DOI] [PubMed] [Google Scholar]
  155. Tomasevic N, Jia Z, Russell A, Fujii T, Hartman JJ, Clancy S, Wang M, Beraud C, Wood KW, Sakowicz R. 2007. Differential regulation of WASP and N-WASP by Cdc42, Rac1, Nck, and PI(4,5)P2. Biochemistry 46: 3494–3502. 10.1021/bi062152y [DOI] [PubMed] [Google Scholar]
  156. Tong L, Tergaonkar V. 2014. Rho protein GTPases and their interactions with NFκB: crossroads of inflammation and matrix biology. Biosci Rep 34: e00115. 10.1042/BSR20140021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Turner CT, Hasanzadeh Kafshgari M, Melville E, Delalat B, Harding F, Mäkilä E, Salonen JJ, Cowin AJ, Voelcker NH. 2016. Delivery of Flightless I siRNA from porous silicon nanoparticles improves wound healing in mice. ACS Biomater Sci Eng 2: 2339–2346. 10.1021/acsbiomaterials.6b00550 [DOI] [PubMed] [Google Scholar]
  158. Turner CT, McInnes SJP, Melville E, Cowin AJ, Voelcker NH. 2017. Delivery of Flightless I neutralizing antibody from porous silicon nanoparticles improves wound healing in diabetic mice. Adv Healthcare Mater 6: 1600707. 10.1002/adhm.201600707 [DOI] [PubMed] [Google Scholar]
  159. Vaid B, Chopra BS, Raut S, Sagar A, Badmalia MD, Ashish KN. 2020. Antioxidant and wound healing property of Gelsolin in 3T3-L1 cells. Oxid Med Cell Longev 2020: 4045365. 10.1155/2020/4045365 [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Van Aelst L, D'Souza-Schorey C. 1997. Rho GTPases and signaling networks. Genes Dev 11: 2295–2322. 10.1101/gad.11.18.2295 [DOI] [PubMed] [Google Scholar]
  161. Van De Water L, Varney S, Tomasek JJ. 2013. Mechanoregulation of the myofibroblast in wound contraction, scarring, and fibrosis: opportunities for new therapeutic intervention. Adv Wound Care (New Rochelle) 2: 122–141. 10.1089/wound.2012.0393 [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Velnar T, Bailey T, Smrkolj V. 2009. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 37: 1528–1542. 10.1177/147323000903700531 [DOI] [PubMed] [Google Scholar]
  163. Vicente-Manzanares M, Sánchez-Madrid F. 2004. Role of the cytoskeleton during leukocyte responses. Nat Rev Immunol 4: 110–122. 10.1038/nri1268 [DOI] [PubMed] [Google Scholar]
  164. Vorobjeva NV, Pinegin BV. 2014. Neutrophil extracellular traps: mechanisms of formation and role in health and disease. Biochemistry (Mosc) 79: 1286–1296. 10.1134/S0006297914120025 [DOI] [PubMed] [Google Scholar]
  165. Vouyiouklis DA, Brophy PJ. 1997. A novel gelsolin isoform expressed by oligodendrocytes in the central nervous system. J Neurochem 69: 995–1005. 10.1046/j.1471-4159.1997.69030995.x [DOI] [PubMed] [Google Scholar]
  166. Welsh CF, Roovers K, Villanueva J, Liu Y, Schwartz MA, Assoian RK. 2001. Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat Cell Biol 3: 950–957. 10.1038/ncb1101-950 [DOI] [PubMed] [Google Scholar]
  167. Wilson SE, Chaurasia SS, Medeiros FW. 2007. Apoptosis in the initiation, modulation and termination of the corneal wound healing response. Exp Eye Res 85: 305–311. 10.1016/j.exer.2007.06.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Witke W, Sharpe AH, Hartwig JH, Azuma T, Stossel TP, Kwiatkowski DJ. 1995. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 81: 41–51. 10.1016/0092-8674(95)90369-0 [DOI] [PubMed] [Google Scholar]
  169. Wittmann J, Dieckow J, Schröder H, Hampel U, Garreis F, Jacobi C, Milczarek A, Hsieh KL, Pulli B, Chen JW, et al. 2018. Plasma gelsolin promotes re-epithelialization. Sci Rep 8: 13140. 10.1038/s41598-018-31441-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H. 2009. Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35: 171–181. 10.1111/j.1524-4725.2008.34406.x [DOI] [PubMed] [Google Scholar]
  171. Wong SL, Demers M, Martinod K, Gallant M, Wang Y, Goldfine AB, Kahn CR, Wagner DD. 2015. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med 21: 815–819. 10.1038/nm.3887 [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Wood W, Jacinto A, Grose R, Woolner S, Gale J, Wilson C, Martin P. 2002. Wound healing recapitulates morphogenesis in Drosophila embryos. Nat Cell Biol 4: 907–912. 10.1038/ncb875 [DOI] [PubMed] [Google Scholar]
  173. Worthylake RA, Lemoine S, Watson JM, Burridge K. 2001. RhoA is required for monocyte tail retraction during transendothelial migration. J Cell Biol 154: 147–160. 10.1083/jcb.200103048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Wu C, Asokan SB, Berginski ME, Haynes EM, Sharpless NE, Griffith JD, Gomez SM, Bear JE. 2012. Arp2/3 is critical for lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis. Cell 148: 973–987. 10.1016/j.cell.2011.12.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Xue M, Jackson CJ. 2015. Extracellular matrix reorganization during wound healing and its impact on abnormal scarring. Adv Wound Care (New Rochelle) 4: 119–136. 10.1089/wound.2013.0485 [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Yang L, Kowalski JR, Zhan X, Thomas SM, Luscinskas FW. 2006. Endothelial cell cortactin phosphorylation by Src contributes to polymorphonuclear leukocyte transmigration in vitro. Circ Res 98: 394–402. 10.1161/01.RES.0000201958.59020.1a [DOI] [PubMed] [Google Scholar]
  177. Zankov DP, Ogita H. 2015. Actin-tethered junctional complexes in angiogenesis and lymphangiogenesis in association with vascular endothelial growth factor. Biomed Res Int 2015: 314178. 10.1155/2015/314178 [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Zarbock A, Kempf T, Wollert KC, Vestweber D. 2012. Leukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation. J Mol Med 90: 353–359. 10.1007/s00109-011-0835-2 [DOI] [PubMed] [Google Scholar]
  179. Zent J, Guo LW. 2018. Signaling mechanisms of myofibroblastic activation: outside-in and inside-out. Cell Physiol Biochem 49: 848–868. 10.1159/000493217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Zhang Z, Li XJ, Liu Y, Zhang X, Li YY, Xu WS. 2007. Recombinant human decorin inhibits cell proliferation and downregulates TGF-β1 production in hypertrophic scar fibroblasts. Burns 33: 634–641. 10.1016/j.burns.2006.08.018 [DOI] [PubMed] [Google Scholar]
  181. Zwetsloot KA, Nedergaard A, Gilpin LT, Childs TE, Booth FW. 2012. Differences in transcriptional patterns of extracellular matrix, inflammatory, and myogenic regulatory genes in myofibroblasts, fibroblasts, and muscle precursor cells isolated from old male rat skeletal muscle using a novel cell isolation procedure. Biogerontology 13: 383–398. 10.1007/s10522-012-9382-7 [DOI] [PubMed] [Google Scholar]

Articles from Cold Spring Harbor Perspectives in Biology are provided here courtesy of Cold Spring Harbor Laboratory Press

RESOURCES